Sign In
Buy PCSA
$2.15
+0.110 (+5.39%)
At Close: Jul 31, 2026
Processa Pharmaceuticals to Present at the World Orphan Drug Congress USA, July 11-13, 2022
08:30am, Tuesday, 12'th Jul 2022
HANOVER, MD., July 12, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical stage biopharmaceutical company developing drugs to improve the
Processa Pharmaceuticals' (PCSA) CEO David Young on Q1 2022 Results - Earnings Call Transcript
01:25pm, Saturday, 14'th May 2022
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Jim Stanker – Chief Financial Officer David Young – Chief Executive Offi
Processa Pharmaceuticals' (PCSA) CEO David Young on Q4 2021 Results - Earnings Call Transcript
08:43pm, Wednesday, 30'th Mar 2022
Processa Pharmaceuticals' (PCSA) CEO David Young on Q4 2021 Results - Earnings Call Transcript
HANOVER, MD, March 23, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of
Processa Pharmaceuticals CEO Dr. David Young To Present at the Oppenheimer 32nd Annual Healthcare Conference
08:30am, Thursday, 10'th Mar 2022
HANOVER, MD, March 10, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to
Processa Pharmaceuticals' (PCSA) CEO David Young on Q3 2021 Results - Earnings Call Transcript
10:40pm, Thursday, 11'th Nov 2021
Processa Pharmaceuticals' (PCSA) CEO David Young on Q3 2021 Results - Earnings Call Transcript
Processa Pharmaceuticals Cleared by FDA to Proceed with Phase 2a Trial for the Treatment of Gastroparesis
08:30am, Tuesday, 12'th Oct 2021
HANOVER, MD, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to i
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences - Update
11:05am, Thursday, 16'th Sep 2021
HANOVER, MD, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
08:30am, Thursday, 16'th Sep 2021
HANOVER, MD, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to
Processa Pharmaceuticals to Present at the World Orphan Drug Congress USA, August 25-27
04:00pm, Monday, 23'rd Aug 2021
HANOVER, MD, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of l
Processa Pharmaceuticals' (PCSA) CEO David Young on Q2 2021 Results - Earnings Call Transcript
11:26pm, Thursday, 12'th Aug 2021
Processa Pharmaceuticals' (PCSA) CEO David Young on Q2 2021 Results - Earnings Call Transcript
Processa Pharmaceuticals Announces Second Quarter 2021 Results and Provides Corporate Update
05:15pm, Thursday, 12'th Aug 2021
Adds fourth clinical asset, RX-3117, and target s major milestones in the second half of 2021
HANOVER, Md., Aug. 06, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical stage biopharmaceutical company developing products to improve the survival and/or quality of
PCSA Stock Price Increases Over 20% Pre-Market: Why It Happened
07:24am, Tuesday, 03'rd Aug 2021
The stock price of Processa Pharmaceuticals Inc (NASDAQ: PCSA) increased by over 20% pre-market. This is why it happened.
Processa Pharmaceuticals to Present at “Zooming with LD Micro” Virtual Investor Event on July 29, 2021 at 12:00 p.m. ET
08:30am, Tuesday, 27'th Jul 2021
HANOVER, MD, July 27, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) announced today that it will be presenting at the upcoming “Zooming with LD Micro” virtual investor eve
